Which is performing better right now, MRK or TMO?

Over the past month MRK is +0.7% and TMO is +6.4%, so TMO is ahead on that window. Year to date the figures are +38.7% for MRK and +19.1% for TMO.

What are the key levels for MRK and TMO?

MRK: resistance $150.00, support $145.12; TMO: resistance $696.49, support $650.00. Levels come from recent swing zones and round numbers, recomputed daily.

When do MRK and TMO report next?

MRK: 2026-10-29. TMO: 2026-10-21. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.

What does the MRK/TMO ratio mean?

It is simply MRK's price divided by TMO's — 0.2115 today. When the ratio rises, MRK is outperforming; when it falls, TMO is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.

MRK vs TMO

Merck & Co. against Thermo Fisher Scientific — live side-by-side technical comparison.

Prices as of 2026-10-16T20:03:27+00:00 UTC · updates daily

Who leads right now

TMO leads 3 of the 5 windows we measure — over 1 month MRK is +0.7% and TMO +6.4%; over year to date MRK is +38.7% and TMO +19.1%. The MRK/TMO price ratio stands at 0.2115, below its 50-day average of 0.2283, and below the 200-day average of 0.2299. A ratio above its own average means MRK is gaining on TMO; on this reading the recent edge belongs to TMO.

Performance side by side

	MRK	TMO
Price	$145.95	$690.00
1 day	+0.5%lead	-0.9%
5 days	+0.2%	+4.9%lead
1 month	+0.7%	+6.4%lead
6 months	+26.4%	+33.7%lead
Year to date	+38.7%lead	+19.1%
52-week position	85% of range	95% of range
52-week range	$82.01–$156.92	$435.27–$704.00
vs 50-day average	above $145.12	above $636.69
vs 200-day average	above $124.87	above $547.32
RSI (14)	45	54
Next earnings	2026-10-29	2026-10-21

Where each one stands

MRK — Merck & Co.

MRK trades at $145.95, above its 50-day average of $145.12, and above the 200-day at $124.87. It sits at 85% of its 52-week range ($82.01–$156.92); 14-day RSI is 45, in neutral territory; an average session moves it about 2.7%. For levels, the first level overhead is $150.00 (2.8% away) and the first support below is $145.12 (0.6% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.

TMO — Thermo Fisher Scientific

TMO trades at $690.00, above its 50-day average of $636.69, and above the 200-day at $547.32. It sits at 95% of its 52-week range ($435.27–$704.00); 14-day RSI is 54, in neutral territory; an average session moves it about 2.9%. For levels, the first level overhead is $696.49 (0.9% away) and the first support below is $650.00 (5.8% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.

Which one moves harder

Both move about the same amount day to day (2.7% and 2.9% of price), so the same position size carries comparable risk in either.

What would change the picture

The comparison turns on those levels: MRK clearing $150.00 or losing $145.12; TMO clearing $696.49 or losing $650.00. Until one of them gives way, the relative reading above stands.

Questions people ask about MRK vs TMO

Which is performing better right now, MRK or TMO?: Over the past month MRK is +0.7% and TMO is +6.4%, so TMO is ahead on that window. Year to date the figures are +38.7% for MRK and +19.1% for TMO.
Is MRK or TMO more volatile?: Both move about the same amount day to day (2.7% and 2.9% of price), so the same position size carries comparable risk in either.
What are the key levels for MRK and TMO?: MRK: resistance $150.00, support $145.12; TMO: resistance $696.49, support $650.00. Levels come from recent swing zones and round numbers, recomputed daily.
When do MRK and TMO report next?: MRK: 2026-10-29. TMO: 2026-10-21. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.
What does the MRK/TMO ratio mean?: It is simply MRK's price divided by TMO's — 0.2115 today. When the ratio rises, MRK is outperforming; when it falls, TMO is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.